Organization
American Lung Association
Type
Foundation
Link
Comments
due dates vary -- see application for each award
Brief Description
- Allergic Respiratory Diseases Award: $75,000/year for up to two years
Jointly funded with the American Academy of Allergy, Asthma & Immunology (AAAAI), this award supports allergic respiratory disease research by investigators with a primary faculty appointment in an allergy-immunology division.
- Catalyst Award: $50,000/year for up to two years
For mentored early career scientists ascending toward independence, this award supports junior investigators conducting basic science, behavioral, clinical or translational research into lung health and disease.
- Dalsemer Interstitial Lung Disease Award: $50,000/year for up to two years
For mentored early career scientists ascending toward independence, this award provides seed monies to junior investigators for researching the mechanisms and biology of interstitial lung disease.
- Emerging Respiratory Pathogen Award: $100,000/year for up to two years (Letter of Intent required)
This award supports investigators to advance knowledge of COVID-19 and other novel respiratory viruses with pandemic potential. Successful applicants have evidence of ongoing excellence and productivity in a related field.
- Hasting Innovation Award for Interstitial Lung Disease: $75,000/year for up to two years
This award is geared toward independent investigators conducting basic, clinical or translational research in interstitial lung disease. Must have held an NIH K- or R-type award within three years prior to applying, but not more than one R01.
- Innovation Award: $75,000/year for up to two years
This award is geared toward independent investigators who are conducting basic science, behavioral, clinical or translational research in lung health or disease. Must have held an NIH K- or R-type award within three years prior, but not more than one R01.
- Lung Cancer Discovery Award: $100,000/year for up to two years (Letter of Intent required)
This award will support independent investigators conducting clinical, laboratory, epidemiological or any groundbreaking project aimed at revolutionizing our understanding of lung cancer and improving diagnostic, clinical and treatment methods.
- Public Policy & Public Health Award: $50,000/year for up to two years
This award is designed to stimulate and inform important public policy debates around healthy air and lung disease. The intent is to support research on and evaluation of existing public policy and public health programs, as well as pilot new ideas.